Edition:
United Kingdom

Acorda Therapeutics Inc (ACOR.OQ)

ACOR.OQ on NASDAQ Stock Exchange Global Select Market

27.80USD
23 Jan 2018
Change (% chg)

$0.25 (+0.91%)
Prev Close
$27.55
Open
$27.30
Day's High
$27.95
Day's Low
$27.00
Volume
115,526
Avg. Vol
209,972
52-wk High
$33.00
52-wk Low
$13.65

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 0.68 December 24 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 1
(2) OUTPERFORM 3 3 3 2
(3) HOLD 5 6 5 5
(4) UNDERPERFORM 2 2 2 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.90 2.91 2.90 2.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 8 132.14 151.50 116.30 --
Quarter Ending Jun-18 8 142.85 166.90 106.14 --
Year Ending Dec-18 11 394.32 623.04 311.00 602.15
Earnings (per share)
Quarter Ending Mar-18 4 0.68 1.09 0.32 --
Quarter Ending Jun-18 4 1.09 1.42 0.82 --
Year Ending Dec-18 6 0.93 2.97 0.04 1.38

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 150.63 141.07 9.57 6.35
Quarter Ending Jun-17 140.07 139.44 0.63 0.45
Quarter Ending Mar-17 127.33 119.39 7.95 6.24
Quarter Ending Dec-16 138.70 140.63 1.93 1.39
Quarter Ending Sep-16 134.01 135.61 1.61 1.20
Earnings (per share)
Quarter Ending Sep-17 0.65 0.43 0.22 34.14
Quarter Ending Jun-17 0.48 0.29 0.19 39.04
Quarter Ending Mar-17 0.09 -0.08 0.17 187.53
Quarter Ending Dec-16 0.12 0.05 0.07 59.61
Quarter Ending Sep-16 0.11 -0.04 0.15 136.36

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 132.14 132.14 131.83 131.68 --
Quarter Ending Jun-18 142.85 143.10 138.49 137.38 --
Year Ending Dec-18 394.32 406.25 403.71 407.86 602.15
Earnings (per share)
Quarter Ending Mar-18 0.68 0.63 0.60 0.60 --
Quarter Ending Jun-18 1.09 1.00 0.82 0.82 --
Year Ending Dec-18 0.93 0.76 0.62 0.62 1.38

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 1 2
Quarter Ending Jun-18 0 1 1 3
Year Ending Dec-18 0 2 1 3
Earnings
Quarter Ending Mar-18 1 0 2 0
Quarter Ending Jun-18 1 0 2 0
Year Ending Dec-18 1 0 2 0